Myria Biosciences is a natural product drug discovery platform using genetically engineered cells to produce drugs.
Myria Biosciences's investors include Creator Fund, Nvidia Inception, Capital Blue Partners, Rockmount Seed Investments Limited.
Myria Biosciences is headquartered in Basel, Switzerland.
Myria Biosciences is a natural product drug discovery platform using genetically engineered cells to produce drugs.
Myria Biosciences is at the Non-equity Assistance stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Myria Biosciences — Funding & Investors." VCBacked, August 20, 2024, https://www.vcbacked.co/company/myria-biosciences. Accessed September 30, 2026.
VCBacked. (2024). Myria Biosciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/myria-biosciences
{{cite web |title=Myria Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/myria-biosciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated